190 related articles for article (PubMed ID: 22353243)
1. Fragment-based design of small RNA binders: promising developments and contribution of NMR.
Moumné R; Catala M; Larue V; Micouin L; Tisné C
Biochimie; 2012 Jul; 94(7):1607-19. PubMed ID: 22353243
[TBL] [Abstract][Full Text] [Related]
2. Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Bodoor K; Boyapati V; Gopu V; Boisdore M; Allam K; Miller J; Treleaven WD; Weldeghiorghis T; Aboul-ela F
J Med Chem; 2009 Jun; 52(12):3753-61. PubMed ID: 19445516
[TBL] [Abstract][Full Text] [Related]
3. Fragment-based drug design.
Feyfant E; Cross JB; Paris K; Tsao DH
Methods Mol Biol; 2011; 685():241-52. PubMed ID: 20981527
[TBL] [Abstract][Full Text] [Related]
4. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
5. Design of screening collections for successful fragment-based lead discovery.
Na J; Hu Q
Methods Mol Biol; 2011; 685():219-40. PubMed ID: 20981526
[TBL] [Abstract][Full Text] [Related]
6. Practical aspects of NMR-based fragment screening.
Lepre CA
Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
[TBL] [Abstract][Full Text] [Related]
7. Design of tRNA(Lys)3 ligands: fragment evolution and linker selection guided by NMR spectroscopy.
Chung F; Tisné C; Lecourt T; Seijo B; Dardel F; Micouin L
Chemistry; 2009 Jul; 15(29):7109-16. PubMed ID: 19544516
[TBL] [Abstract][Full Text] [Related]
8. Discovery of ligands by a combination of computational and NMR-based screening: RNA as an example target.
Mayer M; James TL
Methods Enzymol; 2005; 394():571-87. PubMed ID: 15808238
[TBL] [Abstract][Full Text] [Related]
9. Effective progression of nuclear magnetic resonance-detected fragment hits.
Eaton HL; Wyss DF
Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
[TBL] [Abstract][Full Text] [Related]
10. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology.
Vulpetti A; Dalvit C
ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in developing small molecules targeting RNA.
Guan L; Disney MD
ACS Chem Biol; 2012 Jan; 7(1):73-86. PubMed ID: 22185671
[TBL] [Abstract][Full Text] [Related]
12. Application of NMR and EPR methods to the study of RNA.
Qin PZ; Dieckmann T
Curr Opin Struct Biol; 2004 Jun; 14(3):350-9. PubMed ID: 15193316
[TBL] [Abstract][Full Text] [Related]
13. Fragment-based ligand discovery.
Fischer M; Hubbard RE
Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
[TBL] [Abstract][Full Text] [Related]
14. Utilization of NMR-derived fragment leads in drug design.
Huth JR; Sun C; Sauer DR; Hajduk PJ
Methods Enzymol; 2005; 394():549-71. PubMed ID: 15808237
[TBL] [Abstract][Full Text] [Related]
15. A combination of
Nagatoishi S; Yamaguchi S; Katoh E; Kajita K; Yokotagawa T; Kanai S; Furuya T; Tsumoto K
Bioorg Med Chem; 2018 May; 26(8):1929-1938. PubMed ID: 29510947
[No Abstract] [Full Text] [Related]
16. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
Moore JM
Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
[TBL] [Abstract][Full Text] [Related]
17. NMR-guided fragment-based approach for the design of tRNA(Lys3) ligands.
Chung F; Tisné C; Lecourt T; Dardel F; Micouin L
Angew Chem Int Ed Engl; 2007; 46(24):4489-91. PubMed ID: 17486554
[No Abstract] [Full Text] [Related]
18. Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.
Jennings LE; Measures AR; Wilson BG; Conway SJ
Future Med Chem; 2014 Feb; 6(2):179-204. PubMed ID: 24467243
[TBL] [Abstract][Full Text] [Related]
19. A general approach for the identification of site-specific RNA binders by 19F NMR spectroscopy: proof of concept.
Kreutz C; Kählig H; Konrat R; Micura R
Angew Chem Int Ed Engl; 2006 May; 45(21):3450-3. PubMed ID: 16622887
[No Abstract] [Full Text] [Related]
20. Solid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils.
Middleton DA
Biochem Soc Trans; 2007 Nov; 35(Pt 5):985-90. PubMed ID: 17956260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
